Microbiology
Main Filters
Microbiology
| ABBOTT MOLECULAR INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 03L78-061 | 0 | - | ||
| 08N45-03C | 0 | - | ||
| 08N50-03B | 0 | - | ||
| 09N17-03B | 0 | - | ||
| 09N21-002 | 0 | - | ||
| 09N21-070 | 0 | - | ||
| 09N21-080 | 0 | - | ||
| 09N21-090 | 0 | - | ||
| 09N43-05B | 0 | - | ||
| 09N46-05A | 0 | - | ||
| 09N46-05B | 0 | - | ||
| 09N46-075 | 0 | - | ||
| 09N46-085 | 0 | - | ||
| 09N46-095 | 0 | - | ||
| 09N61-03A | 0 | - | ||
| 09N61-085 | 0 | - | ||
| 09N61-095 | 0 | - | ||
| BIOMERIEUX , INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 9.04 | 0 | - | ||
| R3.1 | 0 | - | ||
| VITEK® 2 AST-N804 | 0 | - | ||
| VITEK® 2 AST-N806 | 0 | - | ||
| VITEK® 2 AST-N807 | 0 | - | ||
| VITEK® 2 AST-N808 | 0 | - | ||
| VITEK® 2 AST-N809 | 0 | - | ||
| VITEK® 2 AST-XN30 | 0 | - | ||
| VITEK® 2 AST-XN31 | 0 | - | ||
| VITEK® 2 AST-XN32 | 0 | - | ||
| BIOMERIEUX SA | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 3.3 | 0 | - | ||
| ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL) | 0 | - | ||
| ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL) | 0 | - | ||
| ETEST® Sulbactam/Durlobactam (SUD) | 0 | - | ||
| ETEST® Tobramycin (TM) | 0 | - | ||
| VITEK MS | 0 | - | ||
| Diagnostic Automation, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1412-1 | 0 | - | ||
| 8043-2 | 0 | - | ||
| 8105-35 | 0 | - | ||
| 8119-35 | 0 | - | ||
| 8202-35 | 0 | - | ||
| 8207-35 | 0 | - | ||
| 8209-35 | 0 | - | ||
| 8212-35 | 0 | - | ||
| NANO-DITECH CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| CD7155 | 0 | - | ||
| CD7156 | 0 | - | ||
| MD8151E | 0 | - | ||
| MD8152 | 0 | - | ||
| TF3161 | 0 | - | ||
| Roche Molecular Systems, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 09446109190 | 0 | - | ||
| 09446117190 | 0 | - | ||
| 09448870190 | 0 | - | ||
| Smith & Nephew | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| E0018191-1 | 0 | - | ||
13,132 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
VITEK® 2 AST-N808
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N807
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N806
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N809
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN32
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN31
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN30
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N804
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK®MS
BIOMERIEUX SA
VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument
0
-
ETEST® Tobramycin (TM)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® Sulbactam/Durlobactam (SUD)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
Nano-Check RSV Test
NANO-DITECH CORPORATION
The Nano-Check RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) nucleoprotein antigen in anterior nasal swab specimens from patients with signs and symptoms of respiratory infection. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients aged 6 months to 6 years old, and adults over 60 years of age.
0
-
Nano-Check Influenza+COVID-19 Dual Test
NANO-DITECH CORPORATION
The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved.
0
-
Nano-CheckTM PCT plus
NANO-DITECH CORPORATION
In Vitro Diagnostic Test kit for the determination of Procalcitonin in human whole blood, serum and plasma
0
-
Fluoro-CheckTM PCT
NANO-DITECH CORPORATION
Fluorescence In Vitro diagnostic test kit for the detection of Procalcitonin in human whole blood, serum or plasma
0
-
Nano-CheckTM PCT
NANO-DITECH CORPORATION
In Vitro Diagnostic Test kit for the determination of Procalcitonin in human whole blood, plasma or serum
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Ascaris IgG ELISAFor the qualitative detection of immunoglobulin G (IgG) antibodies to the parasitic nematode Ascaris lumbricoides in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag ™Mycoplasma pneumoniae IgM Test System provides a means for the qualitative detection of IgM antibodies to Mycoplasma pneumoniae in human sera.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Trichinella IgG ELISA - For the qualitative detection of immunoglobulin G (IgG) antibodies to the parasitic nematode Trichinella species in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Taenia.solium (Cysticercosis) IgG ELISA -For the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to Taenia solium in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Schistosoma IgG ELISA - For the qualitative detection of immunoglobulin G (IgG) antibodies to multiple species of the parasitic flatworm Schistosoma in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag ™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to VZV in human sera.
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott RealTime CMV m2000 System Combined Application CD-ROM
